Neuropharmacological effect of atomoxetine on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy
Neuropharmacological effect of atomoxetine on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy
复制标题
使用功能性近红外光谱评估托莫西汀对注意缺陷多动障碍儿童在奇怪范式中注意力网络的神经药理学作用
DOI:
10.1117/1.nph.1.2.025007
复制
发表时间:
2014
期刊:
影响因子:
5.3
通讯作者:
Eiju Watanabe
中科院分区:
文献类型:
--
作者:
Masako Nagashima;Yukifumi Monden;Ippeita Dan;Haruka Dan;Tsutomu Mizutani;Daisuke Tsuzuki;Yasushi Kyutoku;Yuji Gunji;Daisuke Hirano;Takamichi Taniguchi;Hideo Shimoizumi;Mariko Y. Momoi;Takanori Yamagata;Eiju Watanabe
The current study aimed to explore the neural substrate for atomoxetine effects on attentional control in school-aged children with attention deficit hyperactivity disorder (ADHD) using functional near-infrared spectroscopy (fNIRS), which can be applied to young children with ADHD more easily than conventional neuroimaging modalities. Using fNIRS, we monitored the oxy-hemoglobin signal changes of 15 ADHD children (6 to 14 years old) performing an oddball task before and 1.5 h after atomoxetine or placebo administration, in a randomized, double-blind, placebo-controlled, crossover design. Fifteen age-, gender-, and intelligence quotient-matched normal controls without atomoxetine administration were also monitored. In the control subjects, the oddball task recruited the right prefrontal and inferior parietal cortices. The right prefrontal and parietal activation was normalized after atomoxetine administration in ADHD children. This was in contrast to our previous study using a similar protocol showing methylphenidate-induced normalization of only the right prefrontal function. fNIRS allows the detection of differential neuropharmacological profiles of both substances in the attentional network: the neuropharmacological effects of atomoxetine to upregulate the noradrenergic system reflected in the right prefrontal and inferior parietal activations and those of methylphenidate to upregulate the dopamine system reflected in the prefrontal cortex activation.